STOCK TITAN

Codexis to Participate at Three Virtual Investment Conferences in November

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

REDWOOD CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will participate at three upcoming virtual investment conferences:

  • Stifel Healthcare Conference on Monday, November 16, 2020 with presentation at 3:20 p.m. Eastern time (12:20 p.m. Pacific time)
     
  • 11th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 17, 2020
     
  • Stephens Annual Investment Conference 2020 on Wednesday, November 18, 2020 with presentation at 1:00 p.m. Eastern time (10:00 a.m. Pacific time)

Live webcasts and replays of the presentations at the Stifel Healthcare Conference and Stephens Annual Investment Conference will be available on the Investors section of the company’s website, http://ir.codexis.com/.

About Codexis, Inc.

Codexis is a leading protein engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis’ proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes. For more information, see www.codexis.com.

Contact:

LHA Investor Relations
Jody Cain, 310-691-7100
jcain@lhai.com

Codexis, Inc.

NASDAQ:CDXS

CDXS Rankings

CDXS Latest News

CDXS Stock Data

261.06M
63.61M
3.22%
82.74%
3.39%
Paint and Coating Manufacturing
Manufacturing
Link
United States of America
REDWOOD CITY

About CDXS

codexis, inc. is a leading protein engineering company applying innovative technologies to unlock the power of proteins™. our proprietary codeevolver® technology platform enables the rapid development and production of highly optimized proteins, custom-designed for your application. codexis’ revolutionary approach to protein engineering starts with an understanding of the desired performance specifications and optimizes a protein specifically to fit these requirements. you get precisely the protein you need for the job you want it to do. guided by proprietary artificial intelligence software and advanced high-throughput screening systems, codexis is able to efficiently generate and introduce function-driven mutations to rapidly improve a protein for its target application. since 2002, codexis’ in-house biochemists, biologists and bioinformatics experts have worked closely with our clients to advance the technologies for protein optimization and production, enabling breakthrough develop